Last Posted: May 31, 2018
- A national study of breast and colorectal cancer patients' decision-making for novel personalized medicine genomic diagnostics.
Issa Amalia M et al. Personalized medicine 2013 May 10(3) 245-256 - Association of patient navigation with care coordination in an Lynch syndrome screening program.
Miesfeldt Susan et al. Translational behavioral medicine 2018 May 8(3) 450-455 - Colorectal cancer screening for average risk adults: 2018 guideline update from the American Cancer Society
MD Andrew et al, Cancer, May 30, 2018 - Integrating TYMS , KRAS and BRAF testing in patients with metastatic colorectal cancer.
Ntavatzikos Anastasios et al. World journal of gastroenterology 2017 Aug 23(32) 5913-5924 - Molecular Determinants of Colon Cancer Susceptibility in the East and West.
Abdel-Rahman W M et al. Current molecular medicine 2017 17(1) 34-45 - Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid Tumours.
Soo Ross Andrew et al. Scientific reports 2016 627826 - Colorectal cancer screening for average]risk adults: 2018 guideline update from the American Cancer Society
MD Andrew et al. Cancer, May 30, 2018 - Annual Report to the Nation: overall cancer mortality continues to decline, prostate cancer mortality has stabilized
NCI, Press Release, May 22, 2018 - Are Some Tumors Just ‘Born to Be Bad’?
NIH Director's blog, May 22, 2018 - Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
GA Margonis et al. JAMA Surgery, May 2018
.png)
No hay comentarios:
Publicar un comentario